EnteroMedics (ETRM) Appoints New Medical Chief
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
EnteroMedics Announces Appointment of Scott A. Shikora, MD, FACS as Executive Vice President of Medical Affairs and Chief Medical Officer
April 6, 2015 10:22 AM EDTST. PAUL, Minn., April 6, 2015 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking therapy to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott A. Shikora, MD, FACS has been named Executive Vice President of Medical Affairs and Chief Medical Officer of EnteroMedics, effective June 1, 2015. In this role, he will lead the Company's medical affairs, clinical and regulatory functions. Dr. Shikora previously served as EnteroMedics' Consulting Chief Medical Officer.  The Company also announced today that Tonya Dowd, MPH, has joined EnteroMedics as Vice President of Reimbursement,... More